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Rational design of enzymes with improved properties,
such as enantioselectivity, usually focuses mutations
within the substrate binding site. On the other hand,
directed evolution of enzymes usually targets the en-
tire protein and discovers beneficial mutations far
from the substrate binding site. In this paper, we pro-
pose an explanation for this discrepancy and show
that a combined approach—random mutagenesis
within the substrate binding site—is better. To increase
the enantioselectivity (E) of a Pseudomonas fluo-
rescens esterase (PFE) toward methyl 3-bromo-2-
methylpropionate, we focused mutagenesis into the
substrate binding site at Trp28, Val121, Phe198, and
Val225. Five of the catalytically active mutants (13%)
showed better enantioselectivity than wild-type PFE.
The increases in enantioselectivity were higher (up to
5-fold, reaching E = 61) than with mutants identified
by random mutagenesis of the entire enzyme.
Introduction
Changing an enzyme’s catalytic properties, such as en-
antioselectivity, is an important practical goal. Enzymes
with high enantioselectivity toward unnatural substrates
help chemists make key pharmaceutical intermediates.
In addition, these changes can also reveal mechanistic
information on the molecular basis for catalytic power
and stereoselectivity of enzymes.
In the last decade, several groups increased the en-
antioselectivity of an enzyme by directed evolution—
repeated random mutagenesis and screening of mu-
tants for improved properties [1–16]. For example,
Reetz’s and Jaeger’s groups increased the enantiosel-*Correspondence: rjk@umn.edu
3 Present address: University of British Columbia, Department of
Biochemistry and Molecular Biology, Vancouver, British Columbia
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sala, Sweden.
5 Present address: University of Minnesota, Department of Bio-
chemistry, Molecular Biology, and Biophysics and the Biotechnol-
ogy Institute, 1479 Gortner Avenue, Saint Paul, Minnesota 55108.ectivity of Pseudomonas aeruginosa lipase (PAL) from
E = 1.1 to E = 26 toward an unnatural substrate by using
four cycles of random mutagenesis and screening [11].
Similarly, we moderately increased the enantioselectiv-
ity of an esterase from Pseudomonas fluorescens (PFE)
from E = 12 to E = 19 by random mutagenesis and
screening [15].
Surprisingly, the enantioselectivity-increasing muta-
tions discovered in these experiments lie far from the
enzyme active site (Figure 1A). The observed enantio-
selectivity changes are given as activation energy dif-
ferences (G‡) to simplify comparison. (The three
deltas stem from the following. The activation free en-
ergy change for a chemical reaction is given by G‡.
Enantioselectivity compares the reactivity of the enanti-
omers and is given by G‡ = −RTlnE. Enantioselectiv-
ity changes caused by mutations compare the enantio-
selectivity before and after mutation and are given by
G‡ = −RTln[Emutant/Ewild-type]).Typically, the Cα of
the mutated amino acid lies 12–14 Å from the stereocen-
ter of the substrate. The closest contact distance may be
shorter, depending on the side chain orientation. These
distant changes increase enantioselectivity by propa-
gating structural changes to the substrate binding site.
In many cases, directed evolution uses multiple mut-
ations to alter or even invert enantioselectivity [17], but
we excluded these examples because we cannot as-
sign the enantioselectivity change to one amino acid. In
contrast, rational designs to increase enantioselectivity
always target the substrate binding site, usually within
10 Å of the substrate’s stereocenter [18–22]. For exam-
ple, the Gly60Ala mutation in a phosphotriesterase,
which increased the enantioselectivity from 21 to
11,000 for hydrolysis of p-nitrophenyl ethyl phenyl
phosphate, was at most 7.6 Å from the phosphorus ste-
reocenter [22]. Why does directed evolution usually dis-
cover distant and not close mutations?
Fully random mutagenesis would create all possible
combinations of the 19 natural amino acids at each po-
sition in a protein. However, this is an impossibly large
number of possibilities—for a 300 amino acid protein,
it is larger than the number of atoms in the universe—
so experimental design limits the randomness in all
random mutagenesis experiments. We refer to all muta-
genesis experiments that contain some randomness as
random mutagenesis. We distinguish between meth-
ods that act on the entire protein from those that act in
a more limited region. For example, error-prone PCR
generates amino acid substitutions by targeting the en-
tire protein. Likewise, DNA shuffling targets the entire
protein by exchanging fragments of related proteins.
On the other hand, saturation mutagenesis acts in a
limited region because it replaces amino acids in se-
lected sites with each of the 19 natural amino acids.
Directed evolution usually uses methods that target
the entire protein and therefore favor distant mutations
for statistical reasons. Only a few amino acid residues
(<10%) form the substrate binding site, and most amino
acid residues lie far away. Imagine a spherical enzyme
with the active site at the center, in which the amino
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46Figure 1. Single Mutations Closer to the
Active Site Increase Enantioselectivity More
Strongly than Single Distant Mutations,
but Closer Amino Acids Are Rarer than Dis-
tant Ones
(A) Location of single mutations that increase
enzyme enantioselectivity as identified by ra-
tional design (solid symbols) or directed evo-
lution (outline symbols). The distance is from
the Cα of the mutated amino acid to the ste-
reocenter of the substrate bound to the en-
zyme or to a key active site residue. The
closest contact may be shorter, depending
on side chain orientations. The observed en-
antioselectivity changes are given as activa-
tion energy differences (G‡) to simplify
comparison. Although the molecular details
differ for each case, closer mutations increase
enantioselectivity more strongly than distant
mutations. The literature data for this figure
are included as Supplemental Data (avail-
able with this article online).
(B) The number of amino acids in each 1 Å
thick shell increases with the radius of the
shell. The line shows the predicted values for
a spherical enzyme with an active site in the
center; see Equation 2 in the text. The points
correspond to the observed numbers in the
X-ray crystal structures of lipase from Pseu-
domonas aeruginosa (PAL, circles) and es-
terase from Pseudomonas fluorescens (PFE,
triangles). The distances are between Cα of
the amino acid residues and the stereo-
center of a modeled bound substrate (a
2-methyl carboxylic acid ester). The ob-
served numbers fit the predicted line well up
to w16 Å, but are lower than predicted be-
yond w16 Å because one reaches the edge of the protein. The number of amino acids is for each thin shell and is not cumulative. For this
reason, it decreases as the shells extend beyond the protein. More than half of the amino acid residues in these enzymes are 13–22 Å from
the active site, and <10% lie within 10 Å of the active site.acid residues form concentric shells around the active F
asite. As one moves outward, each shell contains more
amino acids. The volume of each thin shell is the differ- l
eence between the volume of a sphere with radius r + d
and the volume of a sphere with radius r (see Equation f
1). The average number of amino acids within this shell
is the volume divided by the average volume occupied m
sby an amino acid residue, which is 141.3 Å3/aa (see
Equation 2) [23]. t
r
(Vthin shell = 4p(rshell2 d + rshelld2 + d33 ) (1) e
h
D
Naa in thin shell =
4p(rshell2 d + rshelld2 + d33 )





tThis prediction agrees with values for 1 Å thick shells
tcalculated from the X-ray structures of two typical en-
azymes of w30 kDa (Pseudomonas aeruginosa lipase
n[24] and Pseudomonas fluorescens esterase [25]) up to
iw16 Å (Figure 1B). The distance is between a key atom
ain the active site and the Cα of an amino acid residue.
dThe side chain may be closer or farther depending on
mthe direction in which it points. Beyond w16 Å the ob-
vserved numbers of amino acids are lower than pre-
dicted because one reaches the edge of the enzyme.or these two examples, more than half of the amino
cid residues lie 13–22 Å from the active site, and <10%
ie within 10 Å of the active site. For larger proteins, the
dges lie farther out, so most amino acids will lie even
arther from the active site.
Practical considerations introduce bias into random
utagenesis methods such as error-prone PCR, DNA
huffling, and related methods. For example, transi-
ions (substitutions between purines [A and G] or py-
imidines [T and C]) are more likely than traversions
substitutions between a purine and a pyrimidine) with
rror-prone PCR [26]. Similarly, crossovers at regions of
igh sequence similarity are more likely to occur when
NA shuffling is used [27]. This bias of DNA shuffling is
esirable because it favors mutations that are most
ikely to yield a properly folded protein. However, be-
ond these biases, random mutagenesis methods that
arget the entire enzyme are biased toward distant mu-
ations. The number of amino acid residues increases
s one moves away from the active site, and the
umber of mutable positions increases as well. In a typ-
cal enzyme (w30 kDa), more than half of the amino
cid residues lie 13–22 Å from the active site, so ran-
om mutagenesis that targets the entire enzyme favors
utations at this distance. For larger enzymes, the fa-
ored distance is even farther from the active site.
In this paper, we show that single random mutations
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47within the substrate binding site of Pseudomonas fluo-
rescens esterase increase enantioselectivity for hydro-
lysis of methyl 3-bromo-2-methylpropionate (MBMP)
more effectively than the method used in our previous
work, which used single random mutations in the entire
protein [15]. The fraction of mutants with increased en-
antioselectivity is much higher (13% versus <1%), and
the changes are much larger (up to 5-fold versus 1.5-
fold). Researchers have previously changed substrate
specificity by using random mutations within the sub-
strate binding site [28–31]. Our target substrate, MBMP,
was chosen for three reasons. First, wild-type PFE
showed moderate enantioselectivity toward this sub-
strate (E = 12[S]). Second, MBMP is a useful bifunc-
tional chiral building block [32–36]. Third, this resolution
is a challenging one, and no good methods exist to
resolve MBMP, as outlined in our previous paper [15].
For example, enzymatic kinetic resolution with a lipase
from Rhizopus delemar has proceeded with only mod-
erate enantioselectivity [32]. The current high price of
enantiopure MBMP (US $90/5 g [Aldrich], which corres-
ponds to $3300/mole) partly reflects this lack of a good
route to this important compound.
Results
Selection of Sites for Saturation Mutagenesis
A homology model of PFE containing the first tetrahe-
dral intermediate for hydrolysis of (R)-MBMP (slow-
reacting enantiomer) revealed which amino acid resi-
dues are close to the substrate’s stereocenter. The
X-ray crystal structure of PFE, solved recently [25], is
very similar to this homology model. We chose four
positions for saturation mutagenesis: Trp28, Val121,
Phe198, and Val225 (Figure 2). The PFE amino acids in
an earlier publication [15] were numbered one higherFigure 2. A Homology Model of PFE Containing the First Tetrahe-
dral Intermediate in Hydrolysis of (R)-MBMP
Four residues, Trp28, Val121, Phe198, and Val225 (stick representa-
tion), lie close to the chiral acyl moiety of Ser94-MBMP (space-
filling representation). The bromine (burgundy) of MBMP orients
towardVal121. His251 is the catalytic histidine.than here because the numbering included the initial
methionine. The X-ray structure shows that the mature
protein lacks this initial methionine. The side chains of
Trp28 and Val225 lie on either side of the acyl binding
region, while the side chains of Val121 and Phe198 lie
above and behind the acyl binding region. All four of
these amino acids are within van der Waals distance of
the substrate (substrate stereocenter to amino acid Cα
distance is 5–7 Å), but two are also directly involved
in the catalytic machinery. The backbone N-H of Trp28
stabilizes the tetrahedral intermediate by making a hy-
drogen bond to the oxyanion oxygen and the backbone
N-H of Val225 stabilizes the side chain orientation of
the catalytic Asp222 by making a hydrogen bond to Oδ.
Mutagenesis and Identification of Catalytically
Active Mutants
We introduced all 19 possible amino acids at the se-
lected sites one at a time by saturation mutagenesis.
This procedure involved copying DNA encoding for PFE
by using polymerase chain extension of both plasmid
strands with primers containing the degenerate codons
at the selected site. The NNK codons gave 32 possible
codons and coded for each of the 20 amino acids at
least once. N represents any of the four nucleotides (A,
T, G, or C); K represents either G or T. Transformation
of this mixture of plasmids into E. coli gave a mixture
of mutants (each transformation yielded >500 colonies).
To ensure that we tested all 19 possible amino acid
substitutions for Trp28 and Val121, we tested 192 colo-
nies, which ensures that we tested >99.8% of the 32
possible codons (assuming equal incorporation) [37].
For the Phe198 library, we tested only 96 colonies, but
this still ensures that we tested 95% of the possible
codons. For the Val225 library, we screened many more
colonies (480), since we did not find more enantioselec-
tive mutants at this position (see below) and wanted to
be sure that we did not miss one.
To identify the catalytically active mutants, we screened
for hydrolysis of p-nitrophenyl acetate. Approximately
half of the mutants retained at least 1% of the catalytic
activity of the wild-type (Figure 3A). Mutants with >10%
of the wild-type activity were classified as active, those
with 1%–10% of the wild-type activity were classified
as less active, and those with <1% of the wild-type ac-
tivity were classified as inactive. This initial assay used
only crude enzyme solution, so that an active, but
poorly expressed mutant would also be classified as
inactive if the overall activity was <1%. While the Trp28
and Val225 libraries showed 37% and 35% active or
less active colonies, respectively, the Phe198 and
Val121 libraries contained 58% and 55% respectively.
Consistent with our expectations, mutation of amino
acid residues involved in catalytic machinery (Trp28
and Val225) gave a smaller proportion of active colonies
than mutation of amino acid residues that only lie close
to the active site. The total number of different mutants
was 76 (19 amino acid substitutions at 4 sites). Since
only approximately half of the colonies were active, we
estimate that we created approximately 38 active mu-
tants. To characterize these mutants, we screened ap-
proximately 1000 colonies to ensure that we tested
each mutant.
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48Figure 3. Activity and Enantioselectivity of
PFE Mutant Colonies
(A) The fraction of colonies that catalyzed
hydrolysis of p-nitrophenyl acetate after ran-
dom mutagenesis at each of the four sites.
Dark gray bars mark active colonies (>10%
of the wild-type activity [WT activity = 1.6 ×
10−3 mol/min/l]); light gray bars mark less
active colonies (1%–10% of the wild-type
activity); white bars mark inactive colonies
(<1% of the wild-type activity). Val225, with
only 15% active clones, was the least toler-
ant to mutations, while Phe198 was most tol-
erant (42% active).
(B) The enantioselectivity for colonies mu-
tated at each site—28 (“X”), 121 (diamonds),
198 (triangles), and 225 (circles)—where the
Quick E values describe the preferential hy-
drolysis of the S-enantiomer. Mutations at
sites 198 and 225 show only small changes
in enantioselectivity, while mutations at sites
28 and 121 showed dramatic increases in
enantioselectivity. The range of Quick E values
for some highly enantioselective mutants is
large (e.g., Trp28Leu values range from 81 to
123) due to errors in measuring the very slow
rate of hydrolysis of the slow-reacting en-
antiomer. The goal of this Quick E screening
was only to identify which mutants were
highly enantioselective, so we did not at-
tempt to increase the accuracy of Quick E
with highly enantioselective enzymes.Enantioselectivity of Active Mutants o
iColorimetric screening with Quick E [38–40] and DNA
sequencing identified five mutants with increased en- w
aantioselectivity (Figure 3B). Both the Trp28 and Val121
libraries contained mutants with dramatically increased E
enantioselectivity, but the Phe198 and Val225 libraries
contained mutants with only small changes in enantio- o
aselectivity. To confirm the enantioselectivity of mutants,
we also measured the enantioselectivity by the end- t
epoint method [41] (endpoint E) in small scale-up reac-
tions with gas chromatography to measure the enantio- w
pmeric purity (Table 1). For the less enantioselective
mutants, the Quick E values agreed with the endpoint a
mE, but for the highly enantioselective mutants (E > 50),
Quick E only identified that they were highly enantiose- i
slective and often overestimated the true enantiose-
lectivity. These errors are due to difficulties measuring 3
Tthe very slow hydrolysis of the slow-reacting enanti-mer. The goal of this Quick E screening was only to
dentify which mutants were highly enantioselective, so
e did not change reference compounds or make other
djustments that could increase the accuracy of Quick
with highly enantioselective enzymes.
Both the Val121 and Trp28 libraries showed numer-
us colonies that expressed PFE variants with high en-
ntioselectivity (Quick E > 50); among these, we iden-
ified five unique mutants with significantly increased
nantioselectivity. The most enantioselective mutants
ere Val121Ser (Quick E = 104), which gave an end-
oint E of 61, and Trp28Leu (Quick E = 100), which gave
n endpoint E of 58. This enantioselectivity is approxi-
ately 5-fold higher than the wild-type enantioselectiv-
ty of 12. Three other mutants with increased enantio-
electivity were Val121Met (Quick E = 76, endpoint E =
6), Trp28Phe (Quick E = 39, endpoint E = 32), and
rp28Tyr (Quick E = 23, endpoint E = 29). Additional
Closer Is Better
49Table 1. Enantioselectivity and Relative Activity toward MBMP of Wild-Type PFE and Variants Discovered by Saturation Mutagenesis within
the Substrate Binding Site
Enzyme Relative Ratea Quick Eb Endpoint Eb G‡ (kcal/mol) G‡ (kcal/mol)
Wild-type 1.0 11 ± 0.9c 12 ± 2 1.5 0
Trp28Leu 1.6 100 ± 20 58 ± 7d 2.4 0.93
Trp28Phe 0.84 39 32 ± 1 2.1 0.58
Trp28Tyr 0.23 23 29 ± 1 2.0 0.52
Trp28Cys ND 11 NDe ND ND
Val121Ser 2.1 104 ± 13 61 ± 1 2.4 0.96
Val121Met 0.75 76 36 ± 1 2.1 0.65
Phe198Leu ND 25 10 ± 1 1.4 −0.11
Phe198Trp ND 3.0 2.2 ± 0.5 0.48 −1.0
Val225Ala ND 7.6 ND ND ND
Val225Ile ND 16 ND ND ND
Val225Ser ND 7.3 ND ND ND
a Hydrolysis toward the fast-reacting enantiomer using purified enzymes, which allowed the amount of protein to be normalized for each
solution. Conditions: 7% acetonitrile; (S)-MBMP, 1.0 mM; BES-Na buffer (pH 7.2), 4.65 mM; Triton X-100, 0.292 mM; enzyme 0.031 mg/ml; p-
nitrophenol, 0.42 mM; total volume, 100 l; 25°C.
b In all cases, PFE favors (S)-MBMP. Enantioselectivities were measured by using unpurified enzyme because the solution did not contain any
other enzymes that catalyzed hydrolysis of MBMP.
c Errors are standard deviations for at least three measurements; entries without errors are single measurements.
d Values are the average of several measurements of enantioselectivity (E). Typical data are: 40% conversion, 62.9% enantiomeric excess for
the remaining starting material, 92.6% enantiomeric excess for the product acid. These values correspond to an enantioselectivity of 50 when
the equations in Chen et al. [41] are used.
e ND, not determined.sequencing identified Trp28Cys as a mutant with en-
antioselectivity similar to wild-type (Quick E = 11 versus
12 for wild-type). The Phe198 and Val225 libraries con-
tained only mutants with enantioselectivity similar to or
lower than the wild-type: Val225Ile (Quick E = 16), Phe1-
98Leu (Quick E = 25, endpoint E = 10), Phe198Trp
(Quick E = 3, endpoint E = 2.2), Val225Ala (Quick E =
7.6), and Val225Ser (Quick E = 7.3). This total of 5
unique mutants with increased enantioselectivity is
13% of the estimated 38 unique active mutants in the
library. This success rate is much higher than the typi-
cal <1% success rate seen when random mutagenesis
throughout the protein is used.
Kinetic Parameters of the Two Best Mutants
Kinetic parameters show that the enantioselectivity in
wild-type PFE stems from a lower kcat for the slow-
reacting R-enantiomer of MBMP. The KM values are
similar for both enantiomers (50 mM for [S] versus 80
mM for [R]), while kcat is significantly higher for the fast-
reacting enantiomer (1900 min−1 for [S] versus 340
min−1 for [R]). Other researchers also found a higher
kcat for the fast-reacting enantiomer for other serine hy-
drolases with chiral substrates [42, 43].
The two best mutations (Trp28Leu and Val121Ser)
increased enantioselectivity by slightly increasing the
reaction rate of the fast-reacting enantiomer, but mainly
by further slowing the reaction rate of the slow-reacting
enantiomer (Table 2). The kcat values for the fast-reacting
enantiomer (3500 min−1 for Trp28Leu, 3300 min−1 for
Val121Ser) were about 2-fold higher than for wild-type
(1900 min−1), and the KM values were all similar (70 mM
for Trp28Leu, 40 for Val121Ser, 50 for wild-type). Thus,
the specificity constants (kcat/KM) for the fast-reacting
enantiomer increased slightly in the mutants: 51,000
min−1M−1 for Trp28Leu; 73,000 for Val121Ser compared
to 36,000 for wild-type. For the slow-reacting enanti-omer, the KM values were again similar (80 mM for
Trp28Leu, 100 for Val121Ser, 80 for wild-type), but the
kcat values decreased 4- to 5-fold in the mutants (70
min−1 for Trp28Leu, 88 for Val121Ser, 340 for wild-type).
This kcat change lowered the specificity constants for
the mutants: 820 min−1M−1 for Trp28Leu; 890 for
Val121Ser compared to 4200 for wild-type.
Trp28Leu and Val121Ser Increase Enantioselectivity
Mainly through Electronic Effects
To identify whether steric or electronic effects are the
main reason for the increased enantioselectivity, we
tested several substrate analogs, Table 3. The chlo-
romethyl substituent in compound 2 has a smaller size
but similar electronic characteristics to the bromo-
methyl substituent in MBMP (compound 1). If the en-
antioselectivity increase in the mutants stems mainly
from electronic interactions, then there should be a
similar increase for compound 2. Indeed, this was the
case (Table 3). For Trp28Leu, the enantioselectivity
increase from wild-type was 0.93 kcal/mol (from E = 12
to E = 58) for MBMP and 0.85 kcal/mol (from E = 11 to
E = 46) for compound 2. For Val121Ser, the enantiose-
lectivity increase from wild-type was 0.99 kcal/mol
(from E = 12 to E = 61) for MBMP and 0.69 kcal/mol
(from E = 11 to E = 35) for compound 2. These results
suggest that the enantioselectivity increases of these
mutants toward MBMP stem mainly from electronic in-
teractions between the bromomethyl substituent and
PFE.
To test the contribution of steric effects, we used
compound 3, in which the isosteric methyl group re-
places the bromo group of MBMP. (The van der Waals
volumes of CH4 and HBr are 17.1 and 17.9 cm3/mol,
respectively [44].) If the enantioselectivity increase in
the mutants stems mainly from steric interactions, then
there should be a similar increase for compound 3. In
Chemistry & Biology
50Table 2. Kinetic Parameters for the PFE-Catalyzed Hydrolysis of (S)- and (R)-MBMP
kcat/KM (kcat/KM)S/(kcat/
Enzyme Enantiomer kcata (min−1) KMa (mM) (min−1M−1) KM)Rb Endpoint E
Wild-type (S) 1,900 50 36,000 8.6 12
(R) 340 80 4,200
Trp28Leu (S) 3,500 70 51,000 62 58
(R) 70 80 820
Val121Ser (S) 3,300 40 73,000 82 61
(R) 88 100 890
a All measurements were performed four times under the following conditions: in a reaction well, 7% acetonitrile; BES buffer (pH 7.2), 4.65
mM; Triton –X-100, 0.29 mM; PFE, 0.031 mg/ml for (S)-MBMP, but higher for (R)-MBMP; p-nitrophenol, 0.42 mM; total volume, 100 l; 25°C.
Substrate concentration: 2.0–17 mM. The substrate did not dissolve above 17 mM.
b The values of (kcat/KM)S/(kcat/KM)R should and do match the endpoint E values within the estimated error limits. We estimate at least ±25%
error on each kinetic parameter, and thus the errors (kcat/KM)S/(kcat/KM)R are at least ±60%.ety in the substrate binding site of PFE, we suggest omer. The Val121Ser mutation causes a similar destabi-
Table 3. Enantioselectivity Changes of PFE and Several Mutants toward MBMP (1) and Several Analogs
E −G‡ (kcal/mol)
Substrate Comment Wild-Type Trp28Leu Val121Ser Trp28Leu Val121Ser
standard 12 (S) 58 (S) 61 (S) 0.93 0.96
similar electronic effects to 1 11 (S) 46 (S) 35 (S) 0.85 0.69
similar steric effects to 1 32 (R) 34 (R) 50 (R) 0.04 0.26
nra nra nra naa naa
The configuration of the fast-reacting enantiomer is shown.contrast with this prediction, we found little change in t
4enantioselectivity of the mutants toward compound 3
(Table 3). For Trp28Leu, the enantioselectivity increase c
ofrom wild-type was 0.93 kcal/mol (from E = 12 to E =
58) for MBMP, but only 0.04 kcal/mol (from E = 32 to b
rE = 34) for compound 3. For Val121Ser, the enantiose-
lectivity increase from wild-type was 0.99 kcal/mol F
p(from E = 12 to E = 61) for MBMP and only 0.26 kcal/
mol (from E = 32 to E = 50) for compound 3. These e
tresults suggest that steric effects do not contribute in
the Trp28Leu mutation, but may contribute a small p
amount in the Val121Ser mutation. It is not obvious how
the Val121Ser mutation could increase steric effects t
bsince the side chain of serine is smaller that that of
valine. t
(Compound 4, which contains substituents of similar
size but differing electronic character, was not a sub- a
rstrate for wild-type PFE, or any of the mutants. This
lack of reactivity is consistent with a sterically restricted e
nacyl binding site in PFE, as suggested by previous sub-
strate mapping [45]. i
2
rProposed Molecular Basis
for Enantioselectivity Increase u
bOf the three possible rotamers for the MBMP acyl moi-a Neither wild-type nor any of the mutants catalyzed hydrolysis of compouhat only one of them is catalytically productive (Figure
). During catalysis, the catalytic histidine forms a bifur-
ated hydrogen bond to the serine Oγ and the OMe
f the substrate. This requirement crowds the sector
etween these two groups; thus, we propose that only
otamers with a hydrogen in this sector (pointing down;
igure 4) are catalytically productive. The catalytically
roductive rotamer for the fast-reacting enantiomer ori-
nts the bromomethyl group toward Trp28, while, for
he slow-reacting enantiomer, the bromomethyl group
oints toward Val121.
We propose that the Trp28Leu and Val121Ser mu-
ations decrease kcat for the slow-reacting enantiomer
y selective destabilization of the transition state for
his enantiomer by using mainly electronic interactions
Figure 4). The Trp28Leu mutation replaces Trp28 with
nonpolar amino acid. We propose that this change
emoves a repulsive electronic interaction between the
lectron-rich indole ring [46] of Trp28 and the electro-
egative bromomethyl group and thus favors rotamers
n which the bromomethyl group lies nearest position
8. For the fast-reacting enantiomer, this rotamer is
eactive, while, for the slow-reacting enantiomer, it is
nreactive. This favoring of unreactive rotamers desta-
ilizes the transition state for the slow-reacting enanti-nd 4. nr = no reaction; na = not applicable.
Closer Is Better
51Figure 4. Proposed Orientation of MBMP in
the Substrate Binding Site of PFE
During catalysis, the catalytic histidine (data
not shown) forms a bifurcated hydrogen
bond to the serine Oγ and the OMe of the
substrate. This requirement crowds the sec-
tor between these two groups; thus, only ro-
tamers with a hydrogen in this sector (point-
ing down) are reactive. Mutations that increase
enantioselectivity favor unreactive orientations
for the slow-reacting enantiomer, thereby de-
stabilizing the transition state. The Val121Ser
mutation introduces a repulsive interaction
between Ser121 and the bromomethyl sub-
stituent, while the Trp28Leu mutation acts on
the other side of the binding site to remove a
repulsive interaction between Trp28 and the
bromomethyl substituents. These changes
favor the unreactive center rotamer for the
slow-reacting enantiomer.lization by adding a polar substituent on the other side
of the binding site. We propose that this change adds
a repulsive electronic interaction between the hydroxyl
group of Ser121 and the bromomethyl group and thus
also favors rotamers in which the bromomethyl group
lies nearest position 28.
This rationale is also consistent with the increased
enantioselectivity of other mutants at positions 28 and
121 and the decreased enantioselectivity of Phe198Trp
(Table 1). Replacing Trp28 with aromatic amino acids
(Phe, Tyr) gives a smaller enantioselectivity increase
than the nonpolar Leu. Likewise, replacing Val121 with
the slightly polar Met gives a smaller enantioselectivity
increase than the more polar Ser. Position 198 lies near
28, so adding a Trp at position 198 is the reverse of the
enantioselectivity-increasing mutations at position 28,
which remove the Trp. Thus, the Phe198Trp mutant
shows a lower enantioselectivity of 3. Rotticci et al. [47,
48] previously proposed a similar repulsive electronic
interaction in Candida antarctica lipase B between the
hydroxyl groups of Ser47 and Thr42 and the bromo
substituent of 1-bromo-2-butanol.
Discussion
Saturation mutagenesis at four positions in the sub-
strate binding site of PFE (Trp28, Val121, Phe198, and
Val225) revealed five mutants (13% of active mutants)
with higher enantioselectivity than wild-type enzyme.
The enantioselectivity improved up to 5-fold. The best
mutations, Val121Ser and Trp28Leu, increased enantio-
selectivity mainly by decreasing kcat for the slow-reacting
enantiomer by using electronic interactions.
Distant mutations can alter an enzyme’s substrate
selectivity and catalytic activity. The examples in Figure
1A show that single distant mutations can increase
enantioselectivity. Hedstrom and coworkers demon-
strated that, in addition to mutations in the substrate
binding site, distant mutation of surface loops was
essential to change the substrate specificity of trypsin
(favors cleavage after Arg or Lys residues) to that of
chymotrypsin (favors cleavage after Phe, Tyr, or Trp res-
idues) [49–51]. Mutation of the substrate binding site
alone deforms it [52] and yields a poor nonspecific pro-
tease. This simple mutation does alter the substratespecificity as intended for ester hydrolysis, presumably
because of the higher intrinsic reactivity of esters as
compared to peptides. Similarly, adding remote substit-
uents to the substrate can increase selectivity. For ex-
ample, human leukocyte elastase favors Cbz-Val-pNP
only 7-fold over Cbz-Phe-pNP, but it favors Boc-Ala-
Ala-Val-SBzl more than 105-fold over Boc-Ala-Ala-
Phe-Sbzl [53]. Arkin and Wells showed that two distant
(second-sphere) mutations increased the catalytic ac-
tivity (kcat/KM) of an esterolytic catalytic antibody 10-
fold [54].
Are single distant mutations the best way to increase
enantioselectivity? One advantage of single distant
mutations may be smaller disruptions of the enzyme’s
active site. Distant mutations can propagate structural
changes to the active site, where they cause subtle
structural changes. Subtle structural changes can sig-
nificantly change the reaction rate. For example, small
(w1 Å) shifts in the active site dramatically changed the
catalytic power of isocitrate dehydrogenase [55, 56].
Closer mutations make larger changes that may disrupt
catalytic activity or enantioselectivity. Indeed, when we
mutated amino acids in the substrate binding site, ap-
proximately half of our mutants were inactive.
In spite of the possible advantages of distant mu-
tations, we suggest that directed evolution with random
mutagenesis of the entire enzyme usually identifies dis-
tant mutations, not because they are better, but be-
cause they are more likely. A complete screening identi-
fies the best mutants, but most directed evolution
experiments do not screen every mutant generated be-
cause it is easier to make mutants than it is to screen
them. In these cases, the mutants identified depend
both on their likelihood of being formed and their ability
to increase enantioselectivity. One directed evolution
experiment in which the researchers did screen all pos-
sible single mutants indeed identified a mutation close
to the active site, not a distant mutation. Using degen-
erate DNA primers, Desantis and coworkers introduced
all 19 alternate amino acids at each targeted position
of a nitrilase. Homology models showed that mutants
with the highest increases in enantioselectivity had
mutations close to the active site [57].
To increase enantioselectivity, several lines of evi-
dence suggest that single closer mutations are more
effective than single distant mutations. Previously, we
Chemistry & Biology
52rused random mutagenesis on the entire PFE to identify
Omore enantioselective mutants. We found single distant
imutations that moderately increased enantioselectivity.
M
In the current work, mutations targeted to the substrate u
binding site increase both the fraction of mutations with
increased enantioselectivity and the size of the increase. H
Koga and coworkers [17] reported a similar strategy to T
Sinvert the enantioselectivity of Burkholderia cepacia
mKWI-56 lipase. Simultaneous mutation of four amino
wacids yielded a mutant with high enantioselectivity for
Mthe opposite enantiomer. Rational design to increase
enzyme enantioselectivity focuses on close mutations S
and yields much larger changes than designs that use U
distant mutations (see Figure 1). Finally, chemical cata- S
lysts and enzymes use the same physical principles to a
ldistinguish enantiomers. Computational and experimen-
Atal studies with organometallic catalysts show that stere-
Todirecting groups close to the reaction center give higher
enantioselectivity than distant ones [58]. A
Our approach does not require a detailed structure of C
the enzyme to work effectively. In our case, a homology N
Tmodel was generated to learn the basic structure of the
Gsubstrate binding site of PFE. For instances in which
(a homology model is not available, a more simplified
Tapproach would be to select positions for mutagenesis
E
from the amino acid sequence of the enzyme based on >
proximity to the catalytic positions (i.e., Ser, His, Asp c
for lipases/esterases). Overall, this strategy looks promis- n
Oing as a general method to increase the enantioselectiv-
mity of enzymes. For improving other properties, like or-
ganic solvent stability, that are not yet understood on a
Emolecular basis, random mutagenesis throughout the
Tentire protein would be the more promising approach.
f
These properties may require mutations distributed c
throughout the protein structure, and there is no evi- v
dence suggesting that active site mutations would be m





Random mutagenesis of an entire enzyme creates t
more mutations far from the active site than close to (
the active site because there are more amino acids p
sfar from the active site than close to the active site.
mIn a typical enzyme, <10% of the amino acid residues
fare within the substrate binding site, while more than
chalf lie 13–22 Å away. If one generates and tests every µ
single amino acid mutant, one finds the best one re- m
gardless of its location. However, incomplete screen- m
ding of libraries targeting the entire enzyme favors dis-
ftant mutations. This bias toward distant mutations
has not been fully recognized. This work showed that
Qmutations close to the active site caused larger and
Emore frequent increases in enantioselectivity than
tdistant mutations previously identified by random p
mutagenesis of the entire enzyme. This work sug- (
gests that random mutagenesis focused on the sub- t
strate binding site is a more efficient strategy than (
8targeting the whole enzyme to improve catalytic prop-




TGeneralChemicals, buffers, and lysozyme were purchased from Sigma-
Aldrich (Oakville, ON). LB media was obtained from Difco Laborato-ies (Detroit, MI). RNase A was from USB Corporation (Cleveland,
H) and DNase I was purchased from Invitrogen Canada Inc. (Burl-
ngton, ON). The Sheldon Biotechnology Center (McGill University,
ontréal, QC) made the primers and sequenced the mutants by
sing dideoxy termination sequencing.
omology Model Containing MBMP Tetrahedral Intermediate
his model was created as previously described [15], by using the
WISS-MODEL automated homology-modeling server [59]. This
odel agrees with the X-ray crystal structure of this esterase,
hich was solved recently [25]. Figure 2 was prepared with Ras-
ol [60].
aturation Mutagenesis
sing the vector pJOE2792 [61, 62] as a template, the QuikChange
ite-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) was used
ccording to the manufacturer’s instructions to construct the four










he plasmid library of saturation mutants was transformed into
. coli DH5α. If needed, the transformation was repeated to get
500 colonies, and colonies were transferred from LB agar plates
ontaining ampicillin (100 µg/ml) to 96-well microplates for over-
ight growth at 37°C in LB medium (100 µl; ampicillin, 100 µg/ml).
vernight culture was used fresh for further experiments, and re-
aining culture was stored in 50% (v/v) glycerol at −20°C.
nzyme Production in 96-Well Format
o hasten the process of protein expression and isolation and thus
acilitate the screening of large numbers of enzymes, bacteria were
ultured in 96-well assay blocks (Costar, Cambridge, MA) as pre-
iously described [15]; each well had a total available volume of 2
l. Fresh overnight culture from microplates (10 µl) was added to
ach well containing LB medium (1 ml; ampicillin, 100 µg/ml), and
he assay block was incubated at 37°C and 325 rpm for approxi-
ately 3 hr, after which time the OD600 was estimated to be 0.5.
rotein expression was then induced by the addition of sterile
hamnose solution to each well (50 µl; 4% w/v), followed by incuba-
ion as described above for 6 hr. The assay blocks were centrifuged
10 min, 2700 × g, 4°C), and the supernatant was removed. The cell
ellet was resuspended in N,N-bis[2-hydroxyethyl]-2-aminoethane-
ulfonic acid (BES) buffer (400 µl; 5 mM [pH 7.2]; lysozyme, 0.4 mg/
l) and incubated at 37°C and 325 rpm for 45 min, followed by
reezing at −20°C. After thawing at room temperature, the lysed
ells were treated with nucleases (RNase A, 10 µg/ml; DNase I, 1.7
g/ml) for 15 min at 37°C and 325 rpm, and then centrifuged (30
in, 2700 × g, 4°C). The supernatant was used for further experi-
ents. Quick E control experiments ensured that no detectable hy-
rolysis of MBMP occurred due to the nucleases, lysozyme, or cell-
ree extracts of nontransformed DH5α.
uick E Screening toward MBMP
nzymatic hydrolyses of pure enantiomers of MBMP were moni-
ored colorimetrically in the presence of a reference compound as
reviously described [40]. Rates of hydrolysis at 25°C of substrate
11 mM R-enantiomer or 1.1 mM S-enantiomer) and resorufin ace-
ate (0.11 mM) or resorufin isobutyrate (0.03 mM) in buffer solution
100 µl; BES, 5 mM [pH 7.2]; Triton X-100, 0.33 mM; acetonitrile,
% v/v; p-nitrophenol, 0.42 mM; enzyme solution, 10% v/v) were
etermined from the change in absorbance at 404 and 574 nm as
function of time by using a microplate reader.
urification of PFE
o determine enantioselectivity by the endpoint method, pure PFEenzyme was desirable so as to avoid competing hydrolysis from
any other enzymes that may be present in the crude preparation.
Closer Is Better
53The His6 tag present on the C terminus of PFE allowed easy purifi-
cation with Ni-NTA agarose resin according to the manufacturer’s
protocol (Qiagen Inc., Mississauga, ON). Overnight culture (1 ml)
was added to LB medium (100 ml; ampicillin, 100 µg/ml) and grown
at 37°C and 200 rpm to an OD600 of 0.5. Protein expression was
induced by the addition of sterile rhamnose (800 µl; 20% w/v) and
incubation for 6 hr at 37°C and 200 rpm. The cells were harvested
by centrifugation (10 min, 3800 × g, 4°C), and the supernatant was
discarded. The cell pellet was resuspended in Buffer A (5 ml/g wet
weight; NaH2PO4, 50 mM; NaCl, 300 mM; imidazole, 10 mM; ad-
justed to pH 8.0 with NaOH), and lysozyme was added to 1 mg/ml.
Incubation at 37°C and 200 rpm for 30 min was followed by a
freeze-thaw cycle at −20°C and room temperature.
The viscosity of the lysate was broken by repeatedly passing the
solution through a sterile 20-gauge syringe needle, and the sample
was centrifuged (10 min, 10,000 × g, 4°C). Ni-NTA agarose resin to
a final concentration of 20% (v/v) was added to the supernatant,
and the mixture was stirred at 4°C for 1 hr. The mixture was loaded
onto a Poly-Prep column (BioRad Laboratories, Mississauga, ON),
drained, and then washed two times with Buffer B (4 ml; NaH2PO4,
50 mM; NaCl, 300 mM; imidazole, 20 mM; adjusted to pH 8.0 with
NaOH). The His6-PFE enzyme was eluted from the column with 4
volumes of Buffer C (0.5 ml; NaH2PO4, 50 mM; NaCl, 300 mM; imid-
azole, 250 mM; adjusted to pH 8.0 with NaOH).
Eluate (2 ml) from the Ni-NTA column containing purified PFE
was exchanged from Buffer C to BES (5 mM [pH 7.2]) by using a
Slide-a-Lyzer (Pierce, Rockford, IL) as per the manufacturer’s in-
structions.
Confirmation of Enantioselectivity by Endpoint Method
Enantioselectivity of the hydrolysis of (±)-MBMP was calculated by
using the method of Chen et al. [41] from the enantiomeric excesses
of both starting ester and esterified acid product determined by GC
on a chiral stationary phase as previously described [45].
Supplemental Data
Supplemental Data including two tables listing all of the literature,
data, and references used to make Figure 1 are available at http://
www.chembiol.com/cgi/content/full/12/1/45/DC1/.
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